Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myelomaMarek Hus, Anna Dmoszyńska, Grzegorz Helbig et al.|Annals of Hematology|2011Cited by 62
Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patientsNorbert Grząśko, Anna Dmoszyńska, Marek Hus et al.|Hematological Oncology|2012Cited by 48